Showing results (101-110 of 223) with videos related to

Sort By:
Pageof 23
Journal of Translational Medicine|October 9, 2012
Comparison of endometrial regenerative cells and bone marrow stromal cellsHuan Wang, Ping Jin, Marianna Sabatino, et al.
Experimental Hematology|March 31, 2025
Assessing the impact of cell isolation method on B cell gene expression using next-generation sequencingAmanda N Henning, Jordan Pardoe, Darryl Owusu-Ansah, et al.
Transfusion|September 21, 2010
Screening plateletpheresis donors for HLA antibodies on two high-throughput platforms and correlation with recipient outcomeKaren Quillen, Consuelito Medrano, Sharon Adams, et al.
Journal of Translational Medicine|October 6, 2006
Comparison of proteomic profiles of serum, plasma, and modified media supplements used for cell culture and expansionSaleh Ayache, Monica C Panelli, Karen M Byrne, et al.
Cancer Immunology, Immunotherapy : CII|November 17, 2017
Cancer vaccine strategies: translation from mice to human clinical trialsJay A Berzofsky, Masaki Terabe, Jane B Trepel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2017
Expression of CD14, IL10, and Tolerogenic Signature in Dendritic Cells Inversely Correlate with Clinical and Immunologic Response to TARP Vaccination in Prostate Cancer PatientsLuciano Castiello, Marianna Sabatino, Jiaqiang Ren, et al.
Journal of Translational Medicine|July 24, 2008
Differentiation of two types of mobilized peripheral blood stem cells by microRNA and cDNA expression analysisPing Jin, Ena Wang, Jiaqiang Ren, et al.
Journal of Translational Medicine|September 15, 2004
Ambiguous allele combinations in HLA Class I and Class II sequence-based typing: when precise nucleotide sequencing leads to imprecise allele identificationSharon D Adams, Kathleen C Barracchini, Deborah Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2020
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell TrialNirali N Shah, Steven L Highfill, Haneen Shalabi, et al.
Pageof 23